Nā lāʻau lapaʻau no ka maʻi maʻi prostatic hyperplasia

Nā lāʻau lapaʻau no ka maʻi maʻi prostatic hyperplasia

ʻO nā ʻōuli liʻiliʻi a paʻa hoʻi e nānā wale ʻia i ka lāʻau lapaʻau i ka manawa o ka hoʻokolokolo olakino makahiki.

nā lāʻauʻona

Nā ʻApalapala. Kōkua nā mea pale Alfa i ka hoʻomaha ʻana i nā olonā i ka prostate a me ka ʻāʻī bladder. Hoʻomaikaʻi kēia i ke kīloi o ka bladder me kēlā me kēia urination, e hoʻēmi ana i nā koi pinepine e mimi. ʻO ka ʻohana alpha blocker me tamsulosin (Flomax®), terazosin (Hytrin®), doxazosin (Cardura®) a me alfuzosin (Xatral®). Hoʻohālikelike kā lākou kekelē o ka pono. ʻIke koke ʻia nā pōmaikaʻi, ma hope o 1 a 2 mau lā o ka mālama ʻana. ʻO kekahi o kēia mau lāʻau i hoʻohana mua ʻia e mālama i ka hypertension, akā ʻo tamsulosin a me alfuzosin e mālama pono i ka hyperplasia prostatic benign.

Hiki i kekahi o kēia mau lāʻau ke hoʻonāukiuki, luhi, a i ʻole ke koko haʻahaʻa. Hiki ke kū i ke kahe haʻahaʻa inā hoʻohana ʻia nā mea pale alpha i ka manawa like me nā lāʻau lapaʻau erectile (sildenafil, vardenafil, a i ʻole tadalafil). Kūkākūkā me kāna kauka.

Nā mea kūpale 5-alpha-reductase. ʻO kēia mau ʻano lāʻau, ʻo finasteride (Proscar®) a me dutasteride (Avodart®) nā ʻāpana, hōʻemi i ka hana o dihydrotestolone. ʻO 5-alpha-reductase kahi hōmona e hoʻohuli i ka testosterone i loko o kāna metabolite hana, dihydrotestolone. ʻO ka hopena ʻoi loa o ka mālama ʻia ma 3 a 6 mau mahina ma hope o ka hoʻomaka ʻana o ka lāʻau. Aia kahi emi o ka nui o ka prostate ma kahi o 25 a 30%. Hoʻokumu kēia mau lāʻau i ka hana erectile ma kahi o 4% o nā kāne e lawe iā lākou. Hoʻonui, hoʻohana ʻia lākou i ka hui pū me nā alpha blockers.

Notes. Hoʻoemi nui ʻo Finasteride i ka makaʻu o ka ulu ʻana i ka maʻi ʻaʻai prostate, e like me kahi noi nui i mālama ʻia i ka makahiki 2003 (the Prostate Cancer Prevent Trial)7. ʻO Paradoxically, i loko o kēia noiʻi, ua hoʻomaopopo nā kānaka noiʻi i kahi hui ma waena o ka finasteride a me kahi ʻike pinepine ʻana o kahi ʻano maʻi ʻaʻai prostate. ʻO ke kuhiakau e hoʻonui ka finasteride i ka makaʻu o ka maʻi ʻaʻai prostate koʻikoʻi ma hope mai ua hōʻole ʻia. ʻIke ʻia i kēia manawa ua ʻike ʻia ka ʻike ʻia o kēia ʻano maʻi ʻaʻai e ka ʻoiaʻiʻo ua hōʻemi ka nui o ka prostate. Kōkua kahi prostate liʻiliʻi i nā hikoko.

Nui. E hōʻoia i ke kauka nāna e unuhi i ka hoʻāʻo koko antigen prostate (PSA) ʻike i ka mālama ʻana me finasteride, kahi e hoʻohaʻahaʻa ai i nā pae PSA. E ʻike hou aʻe e pili ana i kēia hōʻike kānana, e ʻike i kā mākou pepa ʻoiaʻiʻo Prostate Cancer.

Hoʻohui hoʻohui. Hoʻomaʻamaʻa ʻia ka lawe ʻana i kahi alfa blocker a me kahi mea kūpiki 5-alpha-reductase i ka manawa like. ʻO ka hui pū ʻana o nā ʻano lāʻau 2 e ʻoi aku ka maikaʻi ma mua o kekahi o lākou i ka hoʻolohi ʻana i ka holomua o ka maʻi a me ka hoʻomaikaʻi ʻana i kāna mau ʻōuli.

Nā hui ʻeha

Inā ʻaʻole lawe mai nā hoʻomaʻamaʻa lāʻau i mea e hoʻomaikaʻi ai, noʻonoʻo ʻia ka lāʻau ʻoki lāʻau. Mai ka makahiki 60, 10 a 30% o nā mea maʻi e ʻimi i ka lāʻau ʻoki e hoʻomaha ai i nā ʻōuli o ka maʻi maʻi prostatic hyperplasia. Pono paha ke ʻoki kino i ka hanana o nā pilikia.

ʻO ka transurethral resection o ka prostate a i ʻole TURP. ʻO kēia ka hana i hana pinepine ʻia, ma muli o ka maikaʻi maikaʻi. Hoʻokomo ʻia kahi mea hana endoscopic ma o ka urethra i ka pākeke. Hāʻawi ia i ka curettage o nā ʻāpana hyperplasied o ka prostate. Hiki ke hoʻokō ʻia kēia hana me ka hoʻohana ʻana i kahi laser.

Aneane 80% o nā kāne e hana i kēia kaʻina hana a laila a ka hoʻēmi ʻana iā retrograde : ma kahi o ka ejaculated, kuhikuhi ʻia ka sperm i loko o ka puhū. Noho maʻamau nā hana o Erectile.

Noka. Ma waho o TURP, nā mea ʻē aʻe, ʻoi aku ka liʻiliʻi o ka invasive e hiki ke luku i ka nui o nā kiko prostate: microwaves (TUMT), radiofrequencies (TUNA) a i ʻole ultrasound. ʻO ke koho o ka hana i hilinaʻi ʻia i waena o nā mea ʻē aʻe i ka nui o nā kiko e lawe ʻia. I kekahi manawa kau ʻia nā paipu lahilahi i ka urethra e hāmama ai kēia lepe. Hana ʻia ka hana ma lalo o ka anesthesia ākea a i ʻole ka laulā, a holo ma kahi o 90 mau minuke. Mai ka 10% a i ka 15% o nā maʻi i hana ʻia e loaʻa i kahi ʻoki ʻelua ma waena o 10 mau makahiki o ka hana.

ʻO ke kuhi Transurethral o ka prostate a i ʻole ITUP. ʻO ka hana i hōʻike ʻia no ka hypertrophy mālie e hoʻonui i ka urethra ma ka hana ʻana i nā ʻoki liʻiliʻi i ka ʻāʻī o ka hakahaka, ma kahi o ka hōʻemi ʻana i ka nui o ka prostate. Hoʻonui kēia hana i ka urination. Hāpai ia i kahi makaʻu liʻiliʻi o nā pilikia. ʻO kona hopena lōʻihi e hoʻomau ʻia e hōʻoia ʻia.

ʻOki kino wehe. Ke nui ka prostate (80 a 100 g) a i ʻole nā ​​pilikia e koi iā ia (mau manawa hou o ka paʻa ʻana o ka mimi, hōʻino nā puʻupaʻa, a me nā mea ʻē aʻe), hiki ke hōʻike ʻia i kahi ʻoki hāmama. Hana ʻia kēia hana ʻoki maʻamau ma lalo o ka anesthesia a pili i ka hana ʻana i kahi ʻokiʻoki ma ka ʻōpū o lalo e lawe i kahi ʻāpana o ka gland prostate. Hiki i kēia hana ke hana i ka ejaculation retrograde, e like me ka hihia me ka resurethral resection. ʻO kekahi hopena ʻē aʻe o ka hana ka urinary incontinence.

Waiho i ka Reply